Perspectives On Premenstrual Syndrome/premenstrual Dysphoric Disorder: Outcomes From A Meeting Of The Latin America Experts Group

dc.creatorBahamondes L.
dc.creatorCordova-Eguez S.
dc.creatorPons J.E.
dc.creatorShulman L.
dc.date2007
dc.date2015-06-30T18:49:49Z
dc.date2015-11-26T14:37:59Z
dc.date2015-06-30T18:49:49Z
dc.date2015-11-26T14:37:59Z
dc.date.accessioned2018-03-28T21:42:39Z
dc.date.available2018-03-28T21:42:39Z
dc.identifier
dc.identifierDisease Management And Health Outcomes. , v. 15, n. 5, p. 263 - 277, 2007.
dc.identifier11738790
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-35348866354&partnerID=40&md5=e0352527b87257701bcf855a09924642
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/104977
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/104977
dc.identifier2-s2.0-35348866354
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1249362
dc.descriptionExperts in the field of obstetrics and gynecology recently met to discuss issues related to the epidemiology, diagnosis, and treatment of premenstrual syndrome/premenstrual dysphoric disorder (PMS/PMDD) in Latin American countries. The experts reviewed the existing accepted guidelines related to these issues and discussed adaptations to the diagnostic criteria and treatment recommendations in order to meet the specific needs of women in Latin American countries. This manuscript provides an overview of key information presented at this meeting and provides an up-to-date assessment of emerging treatment options covered in existing guidelines and treatment reviews. In addition, we discuss the relevance and possible application of this expanded knowledge to Latin American countries and provide practical recommendations for the diagnosis and management of PMS/PMDD in this setting. © 2007 Adis Data Information BV. All rights reserved.
dc.description15
dc.description5
dc.description263
dc.description277
dc.descriptionHylan, T.R., Sundell, K., Judge, R., The impact of premenstrual symptomatology on functioning and treatment seeking behaviour: Experience from the United States, United Kingdom and France (1999) J Womens Health Gend Based Med, 8, pp. 1043-1052
dc.descriptionGise, L.H., Kase, N.G., Berkowitz, R.L., Contemporary issues in obstetrics and gynaecology (1988) The premenstrual syndromes, 2. , New York: Churchill Livingstone
dc.descriptionHalbreich, U., Borenstein, J., Pearlstein, T., The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) (2003) Psychoneuroendocrinology, 28 (SUPPL. 3), pp. 1-23
dc.descriptionJohnson, S.R., The epidemiology and social impact of premenstrual symptoms (1987) Clin Obstet Gynecol, 30 (2), pp. 367-376
dc.descriptionAmerican College of Obstetricians and Gynecologists. Premenstrual syndrome. Washington, DC: National Guideline Clearinghouse, 2000(1994) Diagnostic and statistical manual of mental disorders, , American Psychiatric Association, 4th ed. Washington, DC: American Psychiatric Association
dc.descriptionPerspectives on PMS/PMDD. Latin America Experts Group meeting
dc.description2007 Jan 24-26
dc.descriptionCancun, MexicoAndersch, B., Wenderstan, C., Hahn, L., Premenstrual complaints: 1. Prevalence of premenstrual symptoms in a Swedish urban population (1986) J Psychosom Obstet Gynaecol, 5, pp. 39-49
dc.descriptionRamcharan, S., Love, E.J., Fick, G.H., The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors (1992) J Clin Epidemiol, 45 (4), pp. 377-392
dc.descriptionDi Giulio, G., Reissing, E.D., Premenstrual dysphoric disorder: Prevalence, diagnostic considerations, and controversies (2006) J Psychosom Obstet Gynaecol, 27 (4), pp. 201-210
dc.descriptionBackström, T., Buchwald, S., The prevalence of PMS and PMDD and the awareness of associated terminology among women of reproductive age in European and Latin American countries [poster] (2005) World Congress of Human Reproduction, , Mar 10-13
dc.descriptionVenice
dc.descriptionBackström, T., PMS and PMDD symptoms have a negative impact on daily life activities and quality of life among women in European and Latin American countries [oral presentation] (2005) World Congress of Human Reproduction, , Mar 10-13
dc.descriptionVenice
dc.descriptionDean, B.B., Borenstein, J.E., A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome (2004) J Occup Environ Med, 46 (7), pp. 649-656
dc.descriptionPMS/PMDD negatively affects daily life activities. Pharmacoeconomics Outcomes News 2005
dc.description476: 3-4Borenstein, J., Chiou, C.F., Dean, B., Estimating direct and indirect costs of premenstrual syndrome (2005) J Occup Environ Med, 47 (1), pp. 26-33
dc.descriptionBorenstein, J.E., Dean, B.B., Endicott, J., Health and economic impact of the premenstrual syndrome (2003) J Reprod Med, 48 (7), pp. 515-524
dc.descriptionEndicott, J., Nee, J., Harrison, W., Daily Record of Severity of Problems (DRSP): Reliability and validity (2006) Ach Womens Ment Health, 9 (1), pp. 41-49
dc.descriptionHalbreich, U., The etiology, biology, and evolving pathology of premenstrual syndromes (2003) Psychoneuroendocrinology, 28 (SUPPL. 3), pp. 55-99
dc.descriptionDalton, K., Dalton, M.E., Guthrie, K., Incidence of the premenstrual syndrome in twins (1987) BMJ, 295 (6605), pp. 1027-1028
dc.descriptionJohnson, S.R., Premenstrual syndrome, premenstrual dysphoric disorder, and be yond: A clinical primer for practitioners (2004) Obstet Gynecol, 104 (4), pp. 845-859
dc.descriptionFacchinetti, F., Genazzani, A.D., Martignoni, E., Neuroendocrine changes in luteal function in patients with premenstrual syndrome (1993) Clin Endocrinol Metab, 76 (5), pp. 1123-1127
dc.descriptionSchmidt, P.J., Nieman, L.K., Danaceau, M.A., Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome (1998) N Engl J Med, 338 (4), pp. 209-216
dc.descriptionOelkers, W.K., Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure (1996) Steroids, 61 (4), pp. 166-171
dc.descriptionChrousos, G.P., Torpy, D.J., Gold, P.W., Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications (1998) Ann Intern Med, 129 (3), pp. 229-240
dc.descriptionCerin, A., Collins, A., Landgren, B.M., Hormonal and biochemical profiles of premenstrual syndrome: Treatment with essential fatty acids (1993) Acta Obstet Gynecol Scand, 72 (5), pp. 337-343
dc.descriptionHalbreich, U., Rojansky, N., Palter, S., Estrogen augments serotonergic activity in postmenopausal women (1995) Biol Psychiatry, 37 (7), pp. 434-441
dc.descriptionMatsumoto, A., Arai, Y., Osanai, M., Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats (1985) Neurosci Res, 2 (5), pp. 412-418
dc.descriptionMcEwen BS, Alves SE, Bulloch K. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997
dc.description48
dc.description5 Suppl. 7: 8-15De Ronchi, D., Muro, A., Marziani, A., Personality disorders and depressive symptoms in late luteal phase dysphoric disorder (2000) Psychother Psychosom, 69 (1), pp. 27-34
dc.descriptionHarlow, B.L., Cohen, L.S., Otto, M.W., Prevalence and predictors of depressive symptoms in older premenstrual women: The Harvard Study of Moods and Cycles (1999) Arch Gen Psychiatr, 56 (5), pp. 418-424
dc.descriptionHendrick, V., Altshuler, L.L., Recurrent mood shifts of premenstrual dysphoric disorder can be mistaken for rapid-cycling bipolar II disorder [letter] (1998) J Clin Psychiatry, 59 (9), pp. 479-480
dc.descriptionBrawman-Mintzer, O., Shriqui, C., Biological basis of generalized anxiety disorder (1997) J Clin Psychiatry, 58 (SUPPL. 3), pp. 16-25
dc.descriptionParry, B.L., Rosenthal, N.E., Tamarkin, L., Treatment of a patient with seasonal premenstrual syndrome (1987) Am J Psychiatry, 144 (6), pp. 762-766
dc.descriptionPraschak-Rieder, N., Willeit, M., Neumeister, A., Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder (2001) J Affect Disord, 63 (1-3), pp. 239-242
dc.descriptionDeuster, P.A., Adera, T., South-Paul, J., Biological, social, and behavioral factors associated with premenstrual syndrome (1999) Arch Fam Med, 8 (2), pp. 122-128
dc.descriptionPerkonigg, A., Yonkers, K.A., Pfister, H., Risk factors for premenstrual dysphoric disorder in a community sample of young women: The role of traumatic events and posttraumatic stress disorder (2004) J Clin Psychiatry, 65 (10), pp. 1314-1322
dc.descriptionCampbell, E.M., Peterkin, D., O'Grady, K., Premenstrual symptoms in general practice patients: Prevalence and treatment (1997) J Reprod Med, 42 (10), pp. 637-646
dc.descriptionSeverino, S.K., Moline, M.L., Premenstrual syndrome (1990) Obstet Gynecol Clin North Am, 17 (4), pp. 889-903
dc.descriptionPrior, J.C., Vigna, Y., Sciarretta, D., Conditioning exercise decreases premenstrual symptoms: A prospective, controlled 6-month trial (1987) Fertil Steril, 47 (3), pp. 402-408
dc.descriptionSteege, J.F., Blumenthal, J.A., The effects of aerobic exercise on premenstrual symp toms in middle-aged women: A preliminary study (1993) J Psychosom Res, 37 (2), pp. 127-133
dc.descriptionFreeman, E.W., Stout, A.L., Endicott, J., Treatment of premenstrual syndrome with a carbohydrate-rich beverage (2002) Int J Gynaecol Obstet, 77 (3), pp. 253-254
dc.descriptionSayegh, R., Schiff, I., Wurtman, J., The effect of a carbohydrate-rich beverage on mood, appetite, and cognitive function in women with premenstrual syndrome (1995) Obstet Gynecol, 86 (4 PART 1), pp. 520-528
dc.descriptionWyatt, K.M., Dimmock, P.W., Jones, P.W., Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: Systematic review (1999) BMJ, 318 (7195), pp. 1375-1381
dc.descriptionThys-Jacobs, S., Starkey, P., Bernstein, D., Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group (1998) Am J Obstet Gynecol, 179 (2), pp. 444-452
dc.descriptionQuaranta, S., Buscaglia, M.A., Meroni, M.G., Pilot study of the efficacy and safety of a modified-release magnesium 250mg tablet (Sincromag) for the treatment of premenstrual syndrome (2007) Clin Drug Investig, 27 (1), pp. 51-58
dc.descriptionFacchinetti, F., Borella, P., Sances, G., Oral magnesium successfully relieves premenstrual mood changes (1991) Obstet Gynecol, 78 (2), pp. 177-181
dc.descriptionFacchinetti, F., Sances, G., Borella, P., Magnesium prophylaxis of menstrual migraine: Effects on intracellular magnesium (1991) Headache, 31 (5), pp. 298-301
dc.descriptionBerger, D., Schaffner, W., Schrader, E., Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS) (2000) Arch Gynecol Obstet, 264 (3), pp. 150-153
dc.descriptionStevinson, C., Ernst, E., A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome (2000) BJOG, 107 (7), pp. 870-876
dc.descriptionChristensen, A.P., Oei, T.P., The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes (1995) J Affect Disord, 33 (1), pp. 57-63
dc.descriptionHunter, M.S., Ussher, J.M., Browne, S., A randomized comparison of psychological (cognitive behavioural therapy), medical (fluoxetine) and combined treatment for women with premenstrual dysphoric disorder (2002) Psychosom Obstet Gynaecol, 23 (3), pp. 193-199
dc.descriptionHunter, M.S., Ussher, J.M., Cariss, M., Medical (Fluoxetine) and psychological (cognitive behavioural therapy) treatment for premenstrual dysphoric disorder: A study of treatment processes (2002) J Psychosom Res, 53 (3), pp. 811-817
dc.descriptionRapkin, A., A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder (2003) Psychoneuroendocrinology, 28 (SUPPL. 3), pp. 39-53
dc.descriptionSmith, S., Rinehart, J.S., Ruddock, V.E., Treatment of premenstrual syndrome with alprazolam: Results of a double-blind, placebo-controlled, randomized crossover clinical trial (1987) Obstet Gynecol, 70 (1), pp. 37-43
dc.descriptionFreeman, E.W., Rickels, K., Sondheimer, S.J., A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome (1995) JAMA, 274 (1), pp. 51-57
dc.descriptionEvans, S.M., Haney, M., Levin, F.R., Mood and performance changes in women with premenstrual dysphoric disorder: Acute effects of alprazolam (1998) Neuropsychopharmacology, 19 (6), pp. 499-516
dc.descriptionSchmidt, P.J., Grover, G.N., Rubinow, D.R., Alprazolam in the treatment of premenstrual syndrome: A double-blind, placebo-controlled trial (1993) Arch Gen Psychiatry, 50 (6), pp. 467-473
dc.descriptionLanden, M., Eriksson, O., Sundblad, C., Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: A comparison of buspirone, nefazodone and placebo (2001) Psychopharmacology (Berl), 155 (3), pp. 292-298
dc.descriptionBancroft, J., Boyle, H., Warner, P., The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes (1987) Clin Endocrinol (Oxf), 27 (2), pp. 171-182
dc.descriptionBrown, C.S., Ling, F.W., Andersen, R.N., Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptom severity and type in a controlled trial (1994) Obstet Gynecol, 84 (5), pp. 779-786
dc.descriptionDi Carlo, C., Palomba, S., Tommaselli, G.A., Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome (2001) Fertil Steril, 75 (2), pp. 380-384
dc.descriptionFreeman, E.W., Sondheimer, S.J., Rickels, K., Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: A controlled study (1997) Psychopharmacol Bull, 33 (2), pp. 303-309
dc.descriptionLeather, A.T., Studd, J.W., Watson, N.R., The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: A placebo-controlled study (1999) Gynecol Endocrinol, 13 (1), pp. 48-55
dc.descriptionMortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab 1991
dc.description72 (2): 252A-FSundstrom, I., Nyberg, S., Bixo, M., Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen (1999) Acta Obstet Gynecol Scand, 78 (10), pp. 891-899
dc.descriptionWest, C.P., Hillier, H., Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome (1994) Hum Reprod, 9 (6), pp. 1058-1063
dc.descriptionWyatt, K.M., Dimmock, P.W., Ismail, K.M., The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: A meta analysis (2004) Bjog, 111 (6), pp. 585-593
dc.descriptionDeeny, M., Hawthorn, R., McKay Hart, D., Low dose danazol in the treatment of the premenstrual syndrome (1991) Postgrad Med J, 67 (787), pp. 450-454
dc.descriptionHahn, P.M., Van Vugt, D.A., Reid, R.L., A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome (1995) Psychoneuroendocrinology, 20 (2), pp. 193-209
dc.descriptionHalbreich, U., Rojansky, N., Palter, S., Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes (1991) Fertil Steril, 56 (6), pp. 1066-1069
dc.descriptionSarno Jr, A.P., Miller Jr, E.J., Lundblad, E.G., Premenstrual syndrome: Beneficial effects of periodic, low-dose danazol (1987) Obstet Gynecol, 70 (1), pp. 33-36
dc.descriptionWatts, J.F., Butt, W.R., Logan Edwards, R., A clinical trial using danazol for the treatment of premenstrual tension (1987) Br J Obstet Gynaecol, 94 (1), pp. 30-34
dc.descriptionFrackiewicz, E.J., Shiovitz, T.M., Evaluation and management of premenstrual syndrome and premenstrual dysphoric disorder (2001) J Am Pharm Assoc (Wash), 41 (3), pp. 437-447
dc.descriptionDimmock, P.W., Wyatt, K.M., Jones, P.W., Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review (2000) Lancet, 356 (9236), pp. 1131-1136
dc.descriptionCohen, L.S., Miner, C., Brown, E.W., Premenstrual daily fluoxetine for premenstrual dysphoric disorder: A placebo-controlled, clinical trial using computerized diaries (2002) Obstet Gynecol, 100 (3), pp. 435-444
dc.descriptionMenkes, D.B., Taghavi, E., Mason, P.A., Fluoxetine's spectrum of action in premenstrual syndrome (1993) Int Clin Psychopharmacol, 8 (2), pp. 95-102
dc.descriptionMiner, C., Brown, E., McCray, S., Weekly luteal-phase dosing with enteric coated fluoxetine 90mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial (2002) Clin Ther, 24 (3), pp. 417-433
dc.descriptionPearlstein, T.B., Stone, A.B., Lund, S.A., Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder (1997) J Clin Psychopharmacol, 17 (4), pp. 261-266
dc.descriptionSteiner, M., Romano, S.J., Babcock, S., The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder (2001) BJOG, 108 (5), pp. 462-468
dc.descriptionSteiner, M., Steinberg, S., Stewart, D., Fluoxetine in the treatment of premenstrual dysphoria: Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group (1995) N Engl J Med, 332 (23), pp. 1529-1534
dc.descriptionStone, A.B., Pearlstein, T.B., Brown, W.A., Fluoxetine in the treatment of late luteal phase dysphoric disorder (1991) J Clin Psychiatry, 52 (7), pp. 290-293
dc.descriptionSu, T.P., Schmidt, P.J., Danaceau, M.A., Fluoxetine in the treatment of premenstrual dysphoria (1997) Neuropsychopharmacology, 16 (5), pp. 346-356
dc.descriptionWood, S.H., Mortola, J.F., Chan, Y.F., Treatment of premenstrual syndrome with fluoxetine: A double-blind, placebo-controlled, crossover study (1992) Obstet Gynecol, 80 (3 PART 1), pp. 339-344
dc.descriptionCohen, L.S., Soares, C.N., Yonkers, K.A., Paroxetine controlled release for premenstrual dysphoric disorder: A double-blind, placebo-controlled trial (2004) Psychosom Med, 66 (5), pp. 707-713
dc.descriptionFreeman, E.W., Rickels, K., Arredondo, F., Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant (1999) J Clin Psychopharmacol, 19 (1), pp. 3-8
dc.descriptionFreeman, E.W., Rickels, K., Sondheimer, S.J., Differential response to antidepres sants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial (1999) Arch Gen Psychiatry, 56 (10), pp. 932-939
dc.descriptionFreeman, E.W., Rickels, K., Sondheimer, S.J., Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder (2004) Am J Psychiatry, 161 (2), pp. 343-351
dc.descriptionHalbreich, U., Bergeron, R., Yonkers, K.A., Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder (2002) Obstet Gynecol, 100 (6), pp. 1219-1229
dc.descriptionJermain, D.M., Preece, C.K., Sykes, R.L., Luteal phase sertraline treatment for premenstrual dysphoric disorder: Results of a double-blind, placebo-controlled, crossover study (1999) Arch Fam Med, 8 (4), pp. 328-332
dc.descriptionPearlstein, T.B., Halbreich, U., Batzar, E.D., Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo (2000) J Clin Psychiatry, 61 (2), pp. 101-109
dc.descriptionSteiner, M., Hirschberg, A.L., Bergeron, R., Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder (2005) Am J Obstet Gynecol, 193 (2), pp. 352-360
dc.descriptionYonkers, K.A., Gullion, C., Williams, A., Paroxetine as a treatment for premenstrual dysphoric disorder (1996) J Clin Psychopharmacol, 16 (1), pp. 3-8
dc.descriptionYonkers, K.A., Halbreich, U., Freeman, E., Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group (1997) JAMA, 278 (12), pp. 983-988
dc.descriptionYonkers, K.A., Halbreich, U., Freeman, E., Sertraline in the treatment of premenstrual dysphoric disorder (1996) Psychopharmacol Bull, 32 (1), pp. 41-46
dc.descriptionFreeman, E.W., Jabara, S., Sondheimer, S.J., Citalopram in PMS patients with prior SSRI treatment failure: A preliminary study (2002) J Womens Health Gend Based Med, 11 (5), pp. 459-464
dc.descriptionWikander, I., Sundblad, C., Andersch, B., Citalopram in premenstrual dysphoria: Is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle? (1998) J Clin Psychopharmacol, 18 (5), pp. 390-398
dc.descriptionFreeman, E.W., Sondheimer, S.J., Sammel, M.D., A preliminary study of luteal phase versus symptom-onset dosing with escitalopram for premenstrual dysphoric disorder (2005) J Clin Psychiatry, 66 (6), pp. 769-773
dc.descriptionSundblad, C., Hedberg, M.A., Eriksson, E., Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: A placebo-controlled trial (1993) Neuropsychopharmacology, 9 (2), pp. 133-145
dc.descriptionSundblad, C., Modigh, K., Andersch, B., Clomipramine effectively reduces premenstrual irritability and dysphoria: A placebo-controlled trial (1992) Acta Psychiatr Scand, 85 (1), pp. 39-47
dc.descriptionFerguson, J.M., SSRI antidepressant medications: Adverse effects and tolerability (2001) Prim Care Companion J Clin Psychiatry, 3 (1), pp. 22-27
dc.descriptionSundstrom-Poromaa, I., Bixo, M., Bjorn, I., Compliance to antidepressant drug therapy for treatment of premenstrual syndrome (2000) J Psychosom Obstet Gynaecol, 21 (4), pp. 205-211
dc.descriptionGraham, C.A., Sherwin, B.B., A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive (1992) J Psychosom Res, 36 (3), pp. 257-266
dc.descriptionBackstrom, T., Hansson-Malmstrom, Y., Lindhe, B.-A., Oral contraceptives in premenstrual syndrome: A randomized comparison of triphasic and monophasic preparations (1992) Contraception, 46, pp. 253-268
dc.descriptionO'Brien, P.M., Craven, D., Selby, C., Treatment of premenstrual syndrome by spironolactone (1979) Br J Obstet Gynaecol, 86 (2), pp. 142-147
dc.descriptionBurnet, R.B., Radden, H.S., Easterbrook, E.G., Premenstrual syndrome and spironolactone (1991) Aust N Z J Obstet Gynaecol, 31 (4), pp. 366-368
dc.descriptionBorenstein, J., Yu, H.T., Wade, S., Effect of an oral contraceptive containing ethinyl estradiol and drospirenone on premenstrual symptomatology and health-related quality of life (2003) J Reprod Med, 48 (2), pp. 79-85
dc.descriptionFoidart, J.M., Wuttke, W., Bouw, G.M., A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel (2000) Eur J Contracept Reprod Health Care, 5 (2), pp. 124-134
dc.descriptionFreeman, E.W., Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder (2002) Eur J Contracept Reprod Health Care, 7 (SUPPL. 3), pp. 27-34,42-43
dc.descriptionPearlstein, T.B., Bachmann, G.A., Zacur, H.A., Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation (2005) Contraception, 72 (6), pp. 414-421
dc.descriptionSangthawan, M., Taneepanichskul, S., A comparative study of monophasic oral contraceptives containing either drospirenone 3mg or levonorgestrel 150 microg on premenstrual symptoms (2005) Contraception, 71 (1), pp. 1-7
dc.descriptionSillem, M., Schneidereit, R., Heithecker, R., Use of an oral contraceptive containing drospirenone in an extended regimen (2003) Eur J Contracept Reprod Health Care, 8 (3), pp. 162-169
dc.descriptionYonkers, K.A., Brown, C., Pearlstein, T.B., Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder (2005) Obstet Gynecol, 106 (3), pp. 492-501
dc.descriptionSullivan, H., Furniss, H., Spona, J., Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity (1999) Fertil Steril, 72 (1), pp. 115-120
dc.descriptionSulak, P.J., Scow, R.D., Preece, C., Hormone withdrawal symptoms in oral contraceptive users (2000) Obstet Gynecol, 95 (2), pp. 261-266
dc.descriptionSociedad Española de Ginecología y Obstetricia (SEGO). Algoritmo terapéutico Síndrome Premenstrual. Documento de Consenso de la Sociedad Española de Ginecología y Obstetricia [online]. Available from URL: http://www.sego.es [Accessed 2007 Sep 19]Foidart, J.M., Added benefits of drospirenone for compliance (2005) Climacteric, 8 (SUPPL. 3), pp. 28-34
dc.descriptionGruber, D.M., Huber, J.C., Melis, G.B., A comparison of the cycle control, safety, and efficacy profile of a 21-day regimen of ethinylestradiol 20mug and drospirenone 3mg with a 21-day regimen of ethinylestradiol 20mug and desogestrel 150mug (2006) Treat Endocrinol, 5 (2), pp. 115-121
dc.descriptionSchultz-Zehden, B., Boschitsch, E., User experience with an oral contraceptive containing ethinylestradiol 30mug and drospirenone 3mg (Yasmin®) in clinical practice (2006) Treat Endocrinol, 5 (4), pp. 251-256
dc.languageen
dc.publisher
dc.relationDisease Management and Health Outcomes
dc.rightsfechado
dc.sourceScopus
dc.titlePerspectives On Premenstrual Syndrome/premenstrual Dysphoric Disorder: Outcomes From A Meeting Of The Latin America Experts Group
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución